JP2022529529A5 - - Google Patents
Info
- Publication number
- JP2022529529A5 JP2022529529A5 JP2021563196A JP2021563196A JP2022529529A5 JP 2022529529 A5 JP2022529529 A5 JP 2022529529A5 JP 2021563196 A JP2021563196 A JP 2021563196A JP 2021563196 A JP2021563196 A JP 2021563196A JP 2022529529 A5 JP2022529529 A5 JP 2022529529A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- seq
- tau
- liposomes
- administering
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962837987P | 2019-04-24 | 2019-04-24 | |
| US62/837,987 | 2019-04-24 | ||
| PCT/US2020/029477 WO2020219646A1 (en) | 2019-04-24 | 2020-04-23 | Heterologous administration of tau vaccines |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022529529A JP2022529529A (ja) | 2022-06-22 |
| JP2022529529A5 true JP2022529529A5 (enExample) | 2023-09-04 |
| JP7617852B2 JP7617852B2 (ja) | 2025-01-20 |
Family
ID=72921263
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021563196A Active JP7617852B2 (ja) | 2019-04-24 | 2020-04-23 | タウワクチンの異種投与 |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US11591377B2 (enExample) |
| EP (1) | EP3965817A4 (enExample) |
| JP (1) | JP7617852B2 (enExample) |
| KR (1) | KR20220005033A (enExample) |
| CN (1) | CN114173812A (enExample) |
| AU (1) | AU2020262899A1 (enExample) |
| BR (1) | BR112021021213A2 (enExample) |
| CA (1) | CA3137884A1 (enExample) |
| EA (1) | EA202192891A1 (enExample) |
| IL (1) | IL287486A (enExample) |
| JO (1) | JOP20210284A1 (enExample) |
| MA (1) | MA55902A (enExample) |
| MX (1) | MX2021012994A (enExample) |
| PH (1) | PH12021552683A1 (enExample) |
| SG (1) | SG11202111770RA (enExample) |
| TW (1) | TW202110478A (enExample) |
| WO (1) | WO2020219646A1 (enExample) |
| ZA (1) | ZA202108168B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111201030B (zh) | 2017-07-25 | 2024-11-01 | 真和制药有限公司 | 通过阻断tim-3和其配体的相互作用治疗癌症 |
| CN111787942B (zh) | 2017-10-25 | 2024-03-29 | 杨森制药公司 | 磷酸化Tau肽的组合物及其用途 |
| WO2020160156A2 (en) | 2019-01-30 | 2020-08-06 | Immutics, Inc. | Anti-gal3 antibodies and uses thereof |
| MY206596A (en) | 2019-02-08 | 2024-12-25 | Janssen Pharmaceuticals Inc | Method of safe administration of phosphorylated tau peptide vaccine |
| US20230181749A1 (en) * | 2020-05-20 | 2023-06-15 | Bicycle TX Limited | Bicyclic peptide ligands specific for nectin-4 and uses thereof |
| EP4157338A4 (en) | 2020-05-26 | 2024-11-13 | TrueBinding, Inc. | METHOD FOR TREATING INFLAMMATORY DISEASES BY GALECTIN-3 BLOCKING |
| CA3228878A1 (en) * | 2021-08-12 | 2023-02-16 | Andrea Pfeifer | Liposomes containing phosphorylated tau peptides for inducing sustained immune responses |
| JP2024538615A (ja) * | 2021-09-29 | 2024-10-23 | ヤンセン ファーマシューティカルズ，インコーポレーテッド | タウホスホペプチドコンジュゲートの安全な投与の方法 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5811310A (en) | 1986-09-30 | 1998-09-22 | Albert Einstein College Of Medicine Of Yeshiva Univ. | The Alz-50 monoclonal antibody and diagnostic assay for alzheimer's disease |
| CA2017507C (en) | 1989-05-25 | 1996-11-12 | Gary Van Nest | Adjuvant formulation comprising a submicron oil droplet emulsion |
| US7408027B1 (en) | 1991-12-06 | 2008-08-05 | Max-Planck-Gesellschaft Zur Forderung Der Wissenchaften | Tools for the diagnosis and treatment of Alzheimer's disease |
| WO1994013795A1 (en) | 1992-12-14 | 1994-06-23 | N.V. Innogenetics S.A. | Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications |
| US7427392B1 (en) | 1994-11-14 | 2008-09-23 | Elan Pharmaceuticals, Inc. | Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau |
| US20020086009A1 (en) | 1996-03-13 | 2002-07-04 | Koichi Ishiguro | Anti-phosphorylated tau protein antibodies and methods for detecting alzheimer`s disease with the use of the same |
| AU5508798A (en) | 1996-11-19 | 1998-06-10 | Trustees Of The University Of Pennsylvania, The | Diagnostic and therapeutic reagents for alzheimer's disease |
| JP2004503747A (ja) | 2000-07-11 | 2004-02-05 | モレキュラー ジェリアトリクス コーポレイション | 結合物質の同定するための試薬と方法 |
| WO2003066649A1 (en) | 2002-02-04 | 2003-08-14 | Biomira Inc. | Immunostimulatory, covalently lipidated oligonucleotides |
| ATE514707T1 (de) | 2002-04-19 | 2011-07-15 | Univ Toronto | Immunologisches verfahren und zusammensetzungen für die behandlung der krankheit von alzheimer |
| US8663650B2 (en) | 2003-02-21 | 2014-03-04 | Ac Immune Sa | Methods and compositions comprising supramolecular constructs |
| US20050261475A1 (en) | 2004-02-13 | 2005-11-24 | Harvard Medical School | Solid-phase capture-release-tag methods for phosphoproteomic analyses |
| US7238788B2 (en) | 2004-02-18 | 2007-07-03 | University Of Iowa Foundation | Antibodies to phosphorylated tau, methods of making and methods of use |
| KR101152557B1 (ko) | 2005-12-12 | 2012-09-07 | 에이씨 이뮨 에스.에이. | 치료 백신 |
| WO2007068105A1 (en) | 2005-12-12 | 2007-06-21 | Robarts Research Institute | Method of diagnosing amyotrophic lateral sclerosis |
| US8012936B2 (en) | 2006-03-29 | 2011-09-06 | New York University | Tau fragments for immunotherapy |
| WO2008140639A2 (en) | 2007-02-08 | 2008-11-20 | Oligomerix, Inc. | Biomarkers and assays for alzheimer's disease |
| CN101965365A (zh) | 2007-10-19 | 2011-02-02 | 伊缪纳斯制药株式会社 | 能够特异性结合Aβ寡聚体的抗体及其应用 |
| HUE055739T2 (hu) * | 2009-03-18 | 2021-12-28 | Ac Immune Sa | Eljárás terápiás alkalmazásra |
| UA107571C2 (xx) | 2009-04-03 | 2015-01-26 | Фармацевтична композиція | |
| CN106390107B (zh) | 2009-06-10 | 2019-12-31 | 纽约大学 | 病理tau蛋白的免疫靶向 |
| JP2013500326A (ja) | 2009-07-30 | 2013-01-07 | ファイザー バクシーンズ エルエルシー | 抗原性タウペプチドおよびその使用 |
| WO2012020124A1 (en) | 2010-08-12 | 2012-02-16 | Ac Immune S.A. | Vaccine engineering |
| JP6027011B2 (ja) * | 2010-10-26 | 2016-11-16 | エーシー イミューン ソシエテ アノニム | 疎水性部分によって修飾されたペプチドを含むリポソームベースの構築物 |
| ME03008B (me) * | 2011-09-19 | 2018-10-20 | Axon Neuroscience Se | Terapija na osnovu proteina i dijagnoza patologije u којој posreduje tau u alcнajмerovoj bolesti |
| JP2017512751A (ja) * | 2014-02-14 | 2017-05-25 | アイピエリアン，インコーポレイティド | タウペプチド、抗タウ抗体、およびそれらの使用方法 |
| BR112016029579A2 (pt) | 2014-06-26 | 2017-08-22 | Janssen Vaccines & Prevention Bv | anticorpos e fragmentos de ligação ao antígeno que se ligam especificamente à proteína tau associada a microtúbulos |
| NZ775762A (en) * | 2015-06-05 | 2025-02-28 | Genentech Inc | Anti-tau antibodies and methods of use |
| UA128383C2 (uk) * | 2016-12-07 | 2024-07-03 | Дженентек, Інк. | Антитіло до тау-білка та спосіб його застосування |
| CN111787942B (zh) | 2017-10-25 | 2024-03-29 | 杨森制药公司 | 磷酸化Tau肽的组合物及其用途 |
| EP3706795A4 (en) | 2017-11-09 | 2021-10-13 | Pinteon Therapeutics Inc. | METHODS AND COMPOSITIONS FOR GENERATING AND USING HUMANIZED CONFORMATION SPECIFIC PHOSPHORYLATED TAU ANTIBODIES |
-
2020
- 2020-04-23 JO JOP/2021/0284A patent/JOP20210284A1/ar unknown
- 2020-04-23 TW TW109113654A patent/TW202110478A/zh unknown
- 2020-04-23 MX MX2021012994A patent/MX2021012994A/es unknown
- 2020-04-23 KR KR1020217038109A patent/KR20220005033A/ko not_active Ceased
- 2020-04-23 JP JP2021563196A patent/JP7617852B2/ja active Active
- 2020-04-23 AU AU2020262899A patent/AU2020262899A1/en not_active Abandoned
- 2020-04-23 SG SG11202111770RA patent/SG11202111770RA/en unknown
- 2020-04-23 US US16/856,400 patent/US11591377B2/en active Active
- 2020-04-23 WO PCT/US2020/029477 patent/WO2020219646A1/en not_active Ceased
- 2020-04-23 BR BR112021021213A patent/BR112021021213A2/pt unknown
- 2020-04-23 EP EP20796144.2A patent/EP3965817A4/en active Pending
- 2020-04-23 MA MA055902A patent/MA55902A/fr unknown
- 2020-04-23 EA EA202192891A patent/EA202192891A1/ru unknown
- 2020-04-23 CN CN202080046201.9A patent/CN114173812A/zh active Pending
- 2020-04-23 PH PH1/2021/552683A patent/PH12021552683A1/en unknown
- 2020-04-23 CA CA3137884A patent/CA3137884A1/en active Pending
-
2021
- 2021-10-21 IL IL287486A patent/IL287486A/en unknown
- 2021-10-22 ZA ZA2021/08168A patent/ZA202108168B/en unknown
-
2023
- 2023-02-20 US US18/171,498 patent/US20230257433A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022529529A5 (enExample) | ||
| US20250326806A1 (en) | Compositions of Phosphorylated Tau Peptides and Uses Thereof | |
| JP2021501147A5 (enExample) | ||
| US11591377B2 (en) | Heterologous administration of tau vaccines | |
| KR20200143422A (ko) | 항-aveta 치료적 백신 | |
| US20250152684A1 (en) | Anti-Alpha-Synuclein Therapeutic Vaccines | |
| JP2023536497A (ja) | 免疫原性化合物 | |
| JP2022533422A5 (enExample) | ||
| JP2025506472A5 (enExample) | ||
| KR20250135293A (ko) | 리포좀 구조체 | |
| CN118660717A (zh) | 抗α-突触核蛋白的治疗性疫苗 | |
| JP2024538615A5 (enExample) | ||
| HK40105209A (zh) | 磷酸化tau肽的组合物及其用途 | |
| EA051687B1 (ru) | Терапевтические вакцины против альфа-синуклеина | |
| HK40039870B (zh) | 磷酸化Tau肽的组合物及其用途 | |
| HK40039870A (en) | Compositions of phosphorylated tau peptides and uses thereof |